TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Scandinavian Biopharma Distribution AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
154,382
|
121,790
|
94,302 |
Financial expenses |
396
|
502
|
193 |
Earnings before taxes |
30,744
|
31,774
|
21,424 |
EBITDA |
30,409
|
32,206
|
21,617 |
Total assets |
83,513
|
67,706
|
44,754 |
Current assets |
82,411
|
67,269
|
44,250 |
Current liabilities |
26,606
|
28,006
|
17,329 |
Equity capital |
965
|
949
|
932 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
4
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
1.2%
|
1.4%
|
2.1% |
Turnover per employee |
38,596
|
40,597
|
31,434 |
Profit as a percentage of turnover |
19.9%
|
26.1%
|
22.7% |
Return on assets (ROA) |
37.3%
|
47.7%
|
48.3% |
Current ratio |
309.7%
|
240.2%
|
255.4% |
Return on equity (ROE) |
3185.9%
|
3348.2%
|
2298.7% |
Change turnover |
32,592
|
27,488
|
12,163 |
Change turnover % |
27%
|
29%
|
15% |
Chg. No. of employees |
1
|
0
|
1 |
Chg. No. of employees % |
33%
|
0%
|
50% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.